scholarly journals A Note on Cost‐Benefit Analysis, the Marginal Cost of Public Funds, and the Marginal Excess Burden of Taxes

2010 ◽  
Author(s):  
Per-Olov Johansson ◽  
Bengt Kriström
Keyword(s):  
Marginal Cost ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Benefit Analysis ◽  
Public Funds ◽  
Excess Burden ◽  
Marginal Excess Burden

scholarly journals Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital

2020 ◽  
Vol 54 ◽  
pp. 94
Author(s):  
Maurilio de Souza Cazarim ◽  
João Paulo Vilela Rodrigues ◽  
Priscila Santos Calcini ◽  
Thomas Einarson ◽  
Leonardo Régis Leira Pereira
Keyword(s):  
Marginal Cost ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
University Hospital ◽  
Cost Ratio ◽  
Benefit Analysis ◽  
Net Benefit ◽  
Hospital Perspective ◽  
Benefit Cost Ratio ◽  
Tertiary Teaching

OBJECTIVE: To perform a cost-benefits analysis of a clinical pharmacy (CP) service implemented in a Neurology ward of a tertiary teaching hospital. METHODS: This is a cost-benefit analysis of a single arm, prospective cohort study performed at the adult Neurology Unit over 36 months, which has evaluated the results of a CP service from a hospital and Public Health System (PHS) perspective. The interventions were classified into 14 categories and the costs identified as direct medical costs. The results were analyzed by the total and marginal cost, the benefit-cost ratio (BCR) and the net benefit (NB). RESULTS: The total 334 patients were followed-up and the highest occurrence in 506 interventions was drug introduction (29.0%). The marginal cost for the hospital and avoided cost for PHS was US$182±32 and US$25,536±4,923 per year; and US$0.55 and US$76.4 per patient/year. The BCR and NB were 0.0, -US$26,105 (95%CI -31,850 – -10,610), -US$27,112 (95%CI -33,160–11,720) for the hospital and; 3.0 (95%CI 1.97–4.94), US$51,048 (95%CI 27,645–75,716) and, 4.6 (95%CI 2.24–10.05), US$91,496 (95%CI 34,700–168,050; p < 0.001) for the PHS, both considering adhered and total interventions, respectively. CONCLUSIONS: The CP service was not directly cost-benefit at the hospital perspective, but it presented savings for forecast cost related to the occurrence of preventable morbidities, measuring a good cost-benefit for the PHS.

Modelling pesticide risk: A marginal cost–benefit analysis of an environmental buffer-zone programme

2010 ◽  
Vol 27 (2) ◽  
pp. 653-661 ◽  
Author(s):  
Stefan Sieber ◽  
David Pannell ◽  
Klaus Müller ◽  
Karin Holm-Müller ◽  
Peter Kreins ◽  
...  
Keyword(s):  
Marginal Cost ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Buffer Zone ◽  
Benefit Analysis

scholarly journals A Comparison of Cost-Benefit and Cost-Effectiveness Analysis in Practice: Divergent Policy Practices in Sweden

2017 ◽  
Vol 5 (2) ◽  
pp. 41-53 ◽  
Author(s):  
Mikael Svensson ◽  
Lars Hultkrantz
Keyword(s):  
Cost Effectiveness ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Transport Sector ◽  
Economic Evaluations ◽  
Benefit Analysis ◽  
Public Funds ◽  
The Public ◽  
Effectiveness Analysis ◽  
The Social

This paper compares the implementation of the two economic evaluation methods Cost-Effectiveness/Utility (CEA/CUA) and Cost-Benefit Analysis (CBA) as tools for allocation of national public funds in the health and transport sector in Sweden, respectively. We compare the recommended values for important economic parameters such as the social discount rate, the marginal cost of public funds, and the explicit and implicit valuation of health, and document a number of substantial and unexplained differences in implementation. Such differences are problematic considering that the increasing use of economic evaluations to guide policy decisions also has implied an overlap of application areas. We conclude with a discussion on the need of a harmonized procedure for economic evaluations in the public sector in order to reduce the risk of inefficient allocations purely due to different applications of the methods. Published: Online February 2017. In print December 2017.

Cost–benefit analysis of China’s Intended Nationally Determined Contributions based on carbon marginal cost curves

2018 ◽  
Vol 227 ◽  
pp. 415-425 ◽  
Author(s):  
Xi Yang ◽  
Fei Teng ◽  
Xiaoqian Xi ◽  
Egor Khayrullin ◽  
Qi Zhang
Keyword(s):  
Marginal Cost ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Benefit Analysis ◽  
Cost Curves ◽  
Nationally Determined Contributions ◽  
Marginal Cost Curves

scholarly journals On Non-Marginal Cost-Benefit Analysis

2010 ◽  
Author(s):  
Simon Dietz ◽  
Cameron J. Hepburn
Keyword(s):  
Marginal Cost ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Benefit Analysis

Principles of Cost-Benefit Analysis for Developing Countries

1996 ◽  
Author(s):  
Caroline L. Dinwiddy ◽  
Francis J. Teal
Keyword(s):  
Developing Countries ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Benefit Analysis
Sign in / Sign up

Export Citation Format

Share Document